Cunningham previously served as CCO for Exact
Sciences and brings more than 20 years of commercial
leadership across healthcare tech, life sciences, and
pharma
SAN
DIEGO, June 3, 2024 /PRNewswire/
-- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA
sequencing and array-based technologies, today announced the
appointment of Everett Cunningham as
Chief Commercial Officer (CCO), effective June
10.
Cunningham will be responsible for building, guiding, and
managing the company's global commercial organization. He brings
extensive commercial experience across the healthcare tech, life
sciences, and pharmaceutical industries. Most recently, Cunningham
served as Chief Commercial Officer at Exact Sciences, where he
oversaw the company's marketing, sales, and customer service
functions. Prior to Exact Sciences, he held various senior
leadership roles at Quest Diagnostics, GE Healthcare, and Pfizer,
where he spent 21 years as a commercial leader.
Cunningham has a demonstrated track record of success in driving
operational excellence, delivering top-line results, and expanding
into new markets. He is known as a strong leader who has
effectively led teams through transformational change to better
serve customers.
"I am thrilled to welcome Everett to the Illumina leadership
team as we work to deliver on Illumina's mission to improve human
health by unlocking the power of the genome," said Jacob Thaysen, Illumina CEO. "He brings
tremendous commercial leadership experience to the role, along with
a passion for solving some of the world's most pressing healthcare
challenges. I am looking forward to seeing all that he and our
global commercial teams can do together, capitalizing on our
leadership position in next generation sequencing, and delivering
the products, services, and solutions that address customers' most
pressing needs."
Cunningham will be relocating to San
Diego. He succeeds Bas
Verhoef, interim CCO and Head of Region, Europe, since January
2024. Verhoef will continue as Head of Region for
Europe beginning June
10.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as a global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical, and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture, and other emerging segments. To
learn more, visit illumina.com and connect with us on X
(Twitter), Facebook, LinkedIn, Instagram, TikTok,
and YouTube.
Contacts
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
Bonny Fowler
740-641-5579
PR@illumina.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/illumina-appoints-everett-cunningham-chief-commercial-officer-302161847.html
SOURCE Illumina, Inc.